Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in transfusion therapy.

S J Beck1

  • 1Division of Clinical Laboratory Science, University of North Carolina, Chapel Hill 27599.

Clinical Laboratory Science : Journal of the American Society for Medical Technology
|June 7, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patterns of blood product use among patients with myelodysplastic syndrome.

Vox sanguinis·2011
Same author

Psychological externships at the Michael Reese Hospital.

Journal of consulting psychology·2010
Same author

Passing the torch: mentoring the next generation of laboratory professionals.

Clinical laboratory science : journal of the American Society for Medical Technology·2005
Same author

Mentoring tomorrow's leaders in education.

Clinical laboratory science : journal of the American Society for Medical Technology·2005
Same author

Laboratory managers' perceptions of the impact of teaching on the clinical laboratory.

Clinical laboratory science : journal of the American Society for Medical Technology·2004
Same author

CLT and CLS job responsibilities: current distinctions and updates.

Clinical laboratory science : journal of the American Society for Medical Technology·2001
Same journal

Evaluation of Diverse Health Professionals' Learning Experience in a Continuing Education Activity for Quality Practices in Molecular Genetic Testing.

Clinical laboratory science : journal of the American Society for Medical Technology·2019
Same journal

Guidelines for Initiating a Research Agenda: Research Design and Dissemination of Results.

Clinical laboratory science : journal of the American Society for Medical Technology·2015
Same journal

Guidelines for Initiating a Research Agenda: Topic Selection and Evidence of Impact.

Clinical laboratory science : journal of the American Society for Medical Technology·2015
Same journal

Autonomy and Privacy in Clinical Laboratory Science Policy and Practice.

Clinical laboratory science : journal of the American Society for Medical Technology·2015
Same journal

The Value of Clinical Laboratory Sciences Research.

Clinical laboratory science : journal of the American Society for Medical Technology·2015
Same journal

From Technical Assistants to Critical Thinkers: From World War II to 2014.

Clinical laboratory science : journal of the American Society for Medical Technology·2015
See all related articles

Recent advances in blood transfusion therapy focus on leukocyte reduction to prevent alloimmunization and CMV transmission. New guidelines for irradiating blood components reduce graft-versus-host disease risk, with blood substitutes under investigation.

Area of Science:

  • Hematology
  • Transfusion Medicine

Background:

  • Blood transfusion therapy is crucial for patient care.
  • Ongoing research aims to enhance transfusion safety and efficacy.

Purpose of the Study:

  • To review recent advancements in blood transfusion therapy.
  • To highlight improvements in blood component processing and safety protocols.

Main Methods:

  • Review of professional journals.
  • Analysis of current American Association of Blood Banks (AABB) recommendations.

Main Results:

  • Leukocyte reduction effectively prevents alloimmunization and cytomegalovirus transmission.
  • New irradiation guidelines (2,500 cGy) reduce transfusion-associated graft-versus-host disease risk.

Related Experiment Videos

  • Leukocyte reduction is not effective for febrile reactions in alloimmunized patients.

    • Conclusions:

    • Key advances include preventing alloimmunization and CMV transmission via leukocyte-reduced products.
    • Reduced risk of transfusion-associated graft-versus-host disease through updated irradiation protocols.
    • Development of hemoglobin-based and fluorocarbon-based blood substitutes shows future promise.